Activity limitations, use of assistive devices, and mortality and clinical events in 25 high-income, middle-income, and low-income countries: an analysis of the PURE study
| dc.authorid | 0000-0002-8356-3137 | |
| dc.authorid | 0000-0002-8636-7174 | |
| dc.contributor.author | Joundi, Raed A. | |
| dc.contributor.author | Hu, Bo | |
| dc.contributor.author | Rangarajan, Sumathy | |
| dc.contributor.author | Leong, Darryl P. | |
| dc.contributor.author | Islam, Shofiqul | |
| dc.contributor.author | Smith, Eric E. | |
| dc.contributor.author | Mirrakhimov, Erkin | |
| dc.date.accessioned | 2025-05-10T19:44:03Z | |
| dc.date.issued | 2024 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description.abstract | Background The focus of most epidemiological studies has been mortality or clinical events, with less information on activity limitations related to basic daily functions and their consequences. Standardised data from multiple countries at different economic levels in different regions of the world on activity limitations and their associations with clinical outcomes are sparse. We aimed to quantify the prevalence of activity limitations and use of assistive devices and the association of limitations with adverse outcomes in 25 countries grouped by different economic levels. Methods In this analysis, we obtained data from individuals in 25 high-income, middle-income, and low-income countries from the Prospective Urban Rural Epidemiological (PURE) study (175 660 participants). In the PURE study, individuals aged 35-70 years who intended to continue living in their current home for a further 4 years were invited to complete a questionnaire on activity limitations. Participant follow-up was planned once every 3 years either by telephone or in person. The activity limitation screen consisted of questions on self-reported difficulty with walking, grasping, bending, seeing close, seeing far, speaking, hearing, and use of assistive devices (gait, vision, and hearing aids). We estimated crude prevalence of self-reported activity limitations and use of assistive devices, and prevalence standardised by age and sex. We used logistic regression to additionally adjust prevalence for education and socioeconomic factors and to estimate the probability of activity limitations and assistive devices by age, sex, and country income. We used Cox frailty models to evaluate the association between each activity limitation with mortality and clinical events (cardiovascular disease, heart failure, pneumonia, falls, and cancer). The PURE study is registered with ClinicalTrials.gov, NCT03225586. Findings Between Jan 12, 2001, and May 6, 2019, 175 584 individuals completed at least one question on the activity limitation questionnaire (mean age 506 years [SD 98]; 103 625 [59%] women). Of the individuals who completed all questions, mean follow-up was 107 years (SD 44). The most common self-reported activity limitations were difficulty with bending (23 921 [136%] of 175 515 participants), seeing close (22 532 [134%] of 167 801 participants), and walking (22 805 [130%] of 175 554 participants); prevalence of limitations was higher with older age and among women. The prevalence of all limitations standardised by age and sex, with the exception of hearing, was highest in low-income countries and middle-income countries, and this remained consistent after adjustment for socioeconomic factors. The use of gait, visual, and hearing aids was lowest in low-income countries and middle-income countries, particularly among women. The prevalence of seeing close limitation was four times higher (6257 [165%] of 37 926 participants vs 717 [40%] of 18 039 participants) and the prevalence of seeing far limitation was five times higher (4003 [106%] of 37 923 participants vs 391 [22%] 2 2%] of 18 038 participants) in low-income countries than in high- income countries, but the prevalence of glasses use in low-income countries was half that in high-income countries. Walking limitation was most strongly associated with mortality (adjusted hazard ratio 132 [95% CI 125-139]) and most consistently associated with other clinical events, with other notable associations observed between seeing far limitation and mortality, grasping limitation and cardiovascular disease, bending limitation and falls, and between speaking limitation and stroke. Interpretation The global prevalence of activity limitations is substantially higher in women than men and in lowincome countries and middle-income countries compared with high-income countries, coupled with a much lower use of gait, visual, and hearing aids. Strategies are needed to prevent and mitigate activity limitations globally, with particular emphasis on low-income countries and women. | |
| dc.description.sponsorship | Marion W Burke endowed chair of the Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit; Ontario Ministry of Health and Long-Term Care; AstraZeneca (Canada); Population Health Research Institute, Hamilton Health Sciences Research Institute; Sanofi-Aventis (France and Canada); Boehringer Ingelheim (Germany and Canada); Servier; United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory; GlaxoSmithKline; International Development Research Centre, Canada; Novartis; Philippines: Philippine Council for Health Research and Development; King Pharma; Poland: Polish Ministry of Science and Higher Education; Argentina: Fundacion ECLA (Estudios Clinicos Latino America); Wroclaw Medical University; Bangladesh: Independent University, Bangladesh and Mitra and Associates; Saudi Arabia: Saudi Heart Association, Dr Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University, Riyadh; Brazil: Hospital Alemo Oswaldo Cruz, So Paulo, Brazil; Canada; Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, Umm AlQura University, Makkah, Saudi Arabia; Dairy Farmers of Canada; South Africa: The North-West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, Faculty of Community and Health Sciences; Sweden; National Dairy Council (US) , Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network; Chile; Swedish state under an agreement between the Swedish Government [DI13-PE11/EXD05-0003]; Universidad de La Frontera; County councils concerning economic support of research and education of doctors; China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development; Swedish Heart and Lung Foundation [6566-04-18062, 6517-777-58228]; Colombia: Colciencias; Swedish Research Council; India: Indian Council of Medical Research; AFA insurance [100-IRDC/BIOTEK 16/6/21 [13/2007], 07-05-IFN-BPH 010]; Malaysia: Ministry of Science, Technology and Innovation of Malaysia; Swedish Council for Health, Working Life and Welfare [600-RMI/LRGS/5/3 [2/2011]]; Ministry of Higher Education of Malaysia; Turkiye: Metabolic Syndrome Society; Universiti Teknologi MARA, Biostatistics & Data Repository Sector, National Institute of Health, Setia Alam; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai; National Registration Department (JPN); Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); [290/W-PURE/2008/0]; [RG-1436-013]; [ALFGBG-966211]; [2021-0345]; [2018-02527]; [16-0334]; [2013-0325] | |
| dc.description.sponsorship | SY is supported by the Marion W Burke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator-initiated study that is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Support from Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, and the Ontario Ministry of Health and Long-Term Care and through unrestricted grants from several pharmaceutical companies, with major contributions from AstraZeneca (Canada) , Sanofi-Aventis (France and Canada) , Boehringer Ingelheim (Germany and Canada) , Servier, and GlaxoSmithKline, and additional contributions from Novartis and King Pharma. The study was also funded by several national or local organisations in participating countries as follows: Argentina: Fundacion ECLA (Estudios Clinicos Latino America) ; Bangladesh: Independent University, Bangladesh and Mitra and Associates; Brazil: Hospital Alem & atilde;o Oswaldo Cruz, S & atilde;o Paulo, Brazil; Canada: unrestricted grant from Dairy Farmers of Canada and the National Dairy Council (US) , Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de La Frontera [DI13-PE11/EXD05-0003] ; China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development; Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228) ; India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant number: 100-IRDC/BIOTEK 16/6/21 [13/2007] , and 07-05-IFN-BPH 010) , Ministry of Higher Education of Malaysia (grant number: 600-RMI/LRGS/5/3 [2/2011] ) , Universiti Teknologi MARA, Biostatistics & Data Repository Sector, National Institute of Health, Setia Alam for the data linkage service, and National Registration Department (JPN) for their willingness to share their mortality records for research purposes, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010) ; occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory; International Development Research Centre, Canada; Philippines: Philippine Council for Health Research and Development; Poland: Polish Ministry of Science and Higher Education (grant number: 290/W-PURE/2008/0) , Wroclaw Medical University; Saudi Arabia: Saudi Heart Association, Dr Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University (Research group number: RG-1436-013) , Riyadh; Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, Umm AlQura University, Makkah, Saudi Arabia; South Africa: The North-West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, Faculty of Community and Health Sciences; Sweden: grants from the Swedish state under an agreement between the Swedish Government and the county councils concerning economic support of research and education of doctors (ALFGBG-966211) ; the Swedish Heart and Lung Foundation (2021-0345) ; the Swedish Research Council (2018-02527) ; AFA insurance (16-0334) ; and the Swedish Council for Health, Working Life and Welfare [2013-0325] ; Turkiye: Metabolic Syndrome Society; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai. Further details on the funding and participating countries and institutions, and on collaborating staff, are shown in the appendix (pp 28-29) . | |
| dc.identifier.doi | 10.1016/S0140-6736(24)01050-X | |
| dc.identifier.endpage | 569 | |
| dc.identifier.issn | 0140-6736 | |
| dc.identifier.issn | 1474-547X | |
| dc.identifier.issue | 10452 | |
| dc.identifier.pmid | 39068950 | |
| dc.identifier.scopus | 2-s2.0-85200583202 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 554 | |
| dc.identifier.uri | https://doi.org/10.1016/S0140-6736(24)01050-X | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/10796 | |
| dc.identifier.volume | 404 | |
| dc.identifier.wos | WOS:001295915500001 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Science Inc | |
| dc.relation.ispartof | Lancet | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WOS_20250302 | |
| dc.subject | Socioeconomic-Factors | |
| dc.subject | Disability | |
| dc.subject | Prevalence | |
| dc.subject | Diseases | |
| dc.subject | Age | |
| dc.subject | Trends | |
| dc.subject | Adults | |
| dc.subject | Hypertension | |
| dc.subject | Territories | |
| dc.subject | Association | |
| dc.title | Activity limitations, use of assistive devices, and mortality and clinical events in 25 high-income, middle-income, and low-income countries: an analysis of the PURE study | |
| dc.type | Article |










